Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 0 | 0 | 0 | 0 | 1,096 |
| Gross Profit | N/A | N/A | N/A | N/A | 1,096 |
| Operating Expenses | 5,902 | 5,887 | 6,134 | 6,159 | 6,682 |
| Operating Income | -5,902 | -5,887 | -6,134 | -6,159 | -5,586 |
| Other Income | 78 | 573 | 79 | 99 | 73 |
| Pre-tax Income | -5,824 | -5,314 | -6,055 | -6,060 | -5,513 |
| Net Income Continuous | -5,824 | -5,314 | -6,055 | -6,060 | -5,513 |
| Net Income | $-5,824 | $-5,314 | $-6,055 | $-6,060 | $-5,513 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.03 | -0.03 | -0.03 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.03 | -0.03 | -0.03 | -0.03 |
| EBITDA(a) | $-5,644 | $-5,630 | $-5,879 | $-5,896 | $-5,313 |